Ticker Details
Vaxcyte, Inc.
IPO Date:	July 12, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$8.88B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.03 | 2.50%
Avg Daily Range (30 D):	$1.10 | 1.90%
Avg Daily Range (90 D):	$1.11 | 2.11%

Institutional Daily Volume
Avg Daily Volume:	.65M
Avg Daily Volume (30 D):	1.03M
Avg Daily Volume (90 D):	1.09M

Trade Size
Avg Trade Size (Sh.):	59
Avg Trade Size (Sh.) (30 D):	55
Avg Trade Size (Sh.) (90 D):	57

Institutional Trades
Total Institutional Trades:	4,157
Avg Institutional Trade:	$3.71M
Avg Institutional Trade (30 D):	$4.09M
Avg Institutional Trade (90 D):	$3.78M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$7.76M
Avg Closing Trade (30 D):	$13.68M
Avg Closing Trade (90 D):	$11.83M
Avg Closing Volume:	148.08K

News

Mar 18, 2026 @ 11:34 PM Positive VAX-31 Phase 1/2 Adult Data Published in ... Source: Vaxcyte, Inc.

Feb 2, 2026 @ 9:05 PM Vaxcyte Announces Closing of $632.5 Million Public... Source: Globe Newswire

Jan 30, 2026 @ 4:33 AM Vaxcyte Announces Pricing of $550 Million Public O... Source: Na

Jan 22, 2026 @ 10:00 PM Vaxcyte Advances Adult and Infant Programs for VAX... Source: Vaxcyte, Inc.

Sep 30, 2025 @ 3:42 PM Thermo Fisher Launches Four-Part Bond Offering Ahe... Source: Vandana Singh

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-4.84	$-1.56	$-1.22
Diluted EPS	$-4.84	$-1.56	$-1.22
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-657.2M	$-212.83M	$-166.57M
Operating Income / Loss	$-811.56M	$-242.38M	$-226.22M
Cost of Revenue
Net Cash Flow	$-768.96M	$-25.52M	$-40.11M
PE Ratio